Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 2, 2000, Pages 241-259

  Bull, Richard J ^a,b  

^a U S DEPARTMENT OF ENERGY   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Chloral hydrate; Dichloroacetate; Liver tumors; Mode of action; Trichloroacetate; Trichloroethylene

Indexed keywords

CHLORAL HYDRATE; DICHLOROACETIC ACID; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CELL DIVISION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALY; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTOXICITY; HEPATOMEGALY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER TUMOR; MALE; METABOLITE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SOMATIC MUTATION; TUMOR GROWTH;

ANIMALIA; RODENTIA;

EID: 0033947603     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s2241     Document Type: Article

References (167)

1. IARC. Dry Cleaning, Some Chlorinated Solvents and other Industrial Chemicals. Chloral and Chloral Hydrate. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 63:4-17; 33-221; 245-268 (1995).
2. Westrick JJ, Mello W, Thomas RF. The groundwater supply survey. J Am Water Worts Assoc 76:52-60 (1984).
3. Abelson PH. Health risk assessment. Regul Toxicol Pharmacol 17:219-223.
4. U.S. Environmental Protection Agency: Proposed Guidelines for Carcinogen Risk Assessment; Notice. Fed Reg 61:17960-10811 (1996).
5. Bull RJ. Drinking water disinfection. In: Environmental Toxicants: Human Exposures and Their Health Effects. 2nd ed (Lippman M, ed). New York:Wiley-Interscience, 2000;267-317.
6. Craun GF. Surface water supplies and health. J Am Water Works Assoc 80:40-52 (1988).
7. Lash LH. Metabolism of trichloroethylene. Environ Health Perspect 108(suppl 2):177-200 (2000).
8. Lash LH. Modes of action of trichloroethylene for kidney tumorigenesis. Environ Health Perspect 108(suppl 2):225-240 (2000).
9. Green T, Mainwaring GW, Foster JR. Trichloroethylene-induced mouse lung tumors: studies of the mode of action and comparisons between species. Fundam Appl Toxicol 37:125-130 (1997).
10. NCI. Carcinogenesis Bioassay of Trichloroethylene. NCI-CG-TR-2. Bethesda, MD:National Cancer Institute, 1976.
11. NTP. Carcinogenesis Studies of Trichloroethylene (without epichlorohydrin) in F344/N Rats and B6C3F1 Mice. NTP TR 243. NIH Publ no. 90-1779. Research Triangle Park, NC:National Toxicology Program, 1990.
12. Maltoni C, Lefemine G, Cotti G. Experimental research on trichloroethylene carcinogenesis. In: Archives of Research on Industrial Carcinogenesis (Maltoni G, Mehlman MA, eds). Princeton, NJ:Princeton Scientific, 1986.
13. NTP. Toxicology and Carcinogenesis Studies of Trichloroethylene in Four Strains of Rats (ACI, August, Marshall, Osborne-Mendel). NTP TR273. NIH publ no. 88-2529. Research Triangle Park, NC:National Toxicology Program, 1988.
14. Henschler D, Romen W, Elsasser HM, Reichert D, Eder E, Radwan Z. Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species. Arch Toxicol 43:237-248 (1980).
15. Henschler D, Elsasser H, Romen H, Eder E. Carcinogenicity study of trichloroethylene, with and without epoxide stabilizers, in mice. J Cancer Res Clin Oncol 107:149-156 (1984).
16. Fukuda K, Takemoto K, Tsuruta H. Inhalation carcinogenicity of trichloroethylene in mice and rats. Ind Health 21:243-254 (1983).
17. Weiss NS. Cancer in relation to occupational exposure to trichloroethylene. Occup Environ Med 53:1-5 (1996).
18. Spirtas R, Stewart PA, Lee JS, Marano DE, Forbes CD, Grauman DJ, Pettigrew HM, Blair A, Hoover RN, Cohen JL. Retrospective cohort study of workers at an aircraft maintenance facility. I: Epidemiological results. Br J Ind Med 48:515-530 (1991).
19. Axelson O, Selden A, Andersson K, Hogstedt C. Updated and expanded Swedish cohort study of trichloroethylene and cancer risk. J Occup Med 36:556-562 (1995).
20. Anttila A, Pukkala E, Sallmen M, Hernberg S, Hemminki K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Med 37:797-806 (1995).
21. Wong O, Morgan R. Final report: Historical prospective mortality study of Hughes Aircraft employees at Air Force plant no. 44. Alameda, CA:ENSR Health Sciences, 1990.
22. Crebelli R, Carere A. Genetic toxicology of 1,1,2-trichloroethylene. Mutat Res 221:11-37 (1989).
23. Fahrig R, Madle S, Baumann H. Genetic toxicology of trichloroethylene (TCE). Mutat Res 340:1-36 (1995).
24. Moore M, Harrington-Brock K. Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene. Environ Health Perspect 108(suppl 2):215-223 (2000).
25. Mirsalis JC, Tyson CK, Loh EN, Steinmetz KL, Bakke JP, Hamilton CM, Spak DK, Spalding JW. Induction of hepatic cell proliferation and unscheduled DNA synthesis in mouse hepatocytes following in vivo treatment. Carcinogenesis 6:1521-1524 (1985).
26. Doolittle DJ, Muller G, Scribner HE. The in vivo, in vitro hepatocyte assay for assessing DNA repair and DNA replication studies in the CD-1 mouse. Food Chem Toxicicol 25:399-405 (1987).
27. Mirsalis JC, Tyson CK, Steinmetz KL, Loh EK, Hamilton CM, Bakke JP, Spalding JW. Measurement of unscheduled DNA synthesis and S-phase synthesis in rodent hepatocytes following in vivo treatment: testing of 24 compounds. Environ Mol Mutagen 14:155-164 (1989).
28. Walles SAS. Induction of single strand breaks in DNA of mice by trichloroethylene and tetrachloroethylene. Toxicol Lett 31:31-35 (1986).
29. Nelson MA, Bull RJ. Induction of strand breaks in DNA by trichloroethylene and metabolites in rat and mouse liver in vivo. Toxicol Appl Pharmacol 94:45-54 (1988).
30. Stott WT, Quast JF, Watanabe PG. The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats. Toxicol Appl Pharmacol 62:137-151 (1982).
31. 2 and interaction of a metabolite with liver DNA in rats and mice. J Toxicol Environ Health 9:797-813 (1982).
32. Bergman K. Interactions of trichloroethylene with DNA in vitro and with RNA and DNA of various mouse tissues in vivo. Arch Toxicol 54:181-193 (1983).
33. Stevens DK, Eyre RJ, Bull RJ. Adduction of hemoglobin and albumin in vivo by metabolites of trichloroethylene, trichloroacetate and dichloroacetate in rats and mice. Fundam Appl Toxicol 19:336-342 (1992).
34. Eyre RJ, Stevens DK, Parker JC, Bull RJ. Acid-labile adducts to protein can be used as indicators of the cysteine S-conjugate pathway of trichloroethene metabolism. J Toxicol Environ Health 46:443-464 (1995).
35. Kautianen A, Vogel JS, Turteltaub KW. Dose-dependent binding of trichloroethylene to hepatic DNA and protein at low doses in mice. Chem-Biol Interact 106:109-121 (1999).
36. Halmes NC, McMillan DC, Oatis JE Jr, Pumford NR. Immunochemical detection of protein adducts in mice treated with trichloroethylene. Chem Res Toxicol 9:451-456 (1996).
37. Toraason M, Clark J, Dankovic D, Mathias P, Skaggs S, Walker C, Werren D. Oxidative stress and DNA damage in Fischer rats following acute exposure to trichlorothylene or perchloroethylene. Toxicology 138:43-53 (1999).
38. Steel-Goodwin L, Pravecek TL, Carmichael AJ. Trichloroethylene metabolism in vitro: an EPR/SPIN trapping study. Human Exp Toxicol 15:878-884 (1996).
39. Cerutti P. Prooxidant states and tumor promotion. Science 227:375-381 (1985).
40. Anna CH, Maronpot RR, Pereira MA, Foley JF, Malarkey DE, Anderson MW. ras Proto-oncogene activation in dichloroacetic-, trichloroethylene-and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis 15:2255-2261 (1994).
41. Reynolds SH, Stowers SJ, Patterson RM, Maronpot RR, Aaronson SA, Anderson MW. Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 237:1309-1316 (1987).
42. Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101:125-156 (1995).
43. Ferreira-Gonzalez A, DeAngelo AB, Nasim S, Garrett CT. Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic and trichloroacetic acids. Carcinogenesis 16:495-500 (1995).
44. Orner GA, Malone JA, Stillwell LC, Cheng RS, Stauber AJ, Sasser LB, Thrall BD, Bull RJ. Effects of trichloroacetate (TCA) and dichloroacetate (DCA) on H-ras in male B6C3F1 mice. Toxicologist 42:60 (1998).
45. Kalkuhl A, Troppmair J, Buchmann A, Stinchcombe S, Buenemann CL, Rapp UR, Kaestner K, Schwarz M. p21 (Ras) downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between RAS-mutated and RAS-wild-type lesions. Hepatology 27:1081-1088 (1998).
46. Schroeder M, DeAngelo AB, Mass MJ. Dichloroacetic acid reduces Ha-ras codon 61 mutations in liver tumors from female B6C3F1 mice. Carcinogenesis 18:1675-1678 (1997).
47. Kato-Weinstein J, Lingohr MK, Thrall BD, Bull RJ. Effects of dichloroacetate-treatment on carbohydrate metabolism in B6C3F1 mice. Toxicology 130:141-154 (1998).
48. Merdink JL, Gonzalez-Leon A, Bull RJ, Schultz IR. The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice. Toxicol Sci 45:33-41 (1998).
49. Barton HA, Bull R, Schultz I, Andersen ME. Dichloroacetate (DCA) dosimetry: interpreting DCA-induced liver cancer dose response and the potential for DCA to contribute to trichloroethylene-induced liver cancer. Toxicol Lett 106:9-21 (1999).
50. Elcombe CR. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch Toxicol (suppl 8):6-17 (1985).
51. Lake BG. Peroxisome proliferation: current mechanisms relating to non-genotoxic carcinogenesis. Toxicol Lett 82/83:673-681 (1995).
52. Cattley RC, DeLuca J, Elcombe C, Fenner-Crisp P, Lake BG, Marsman DS, Pastoor TA, Popp JA, Robinson DE, Schwetz B, et al. Do peroxisome proliferating compounds pose a carcinogenic hazard to humans. Regul Toxicol Pharmacol 27:47-60 (1997).
53. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (Lond) 347:645-650 (1990).
54. Larson JL, Bull RJ. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol Appl Pharmacol 115:273-285 (1992).
55. Lee S-T, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022 (1995).
56. Peters JM, Cattley RC, Gonzalez FJ. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator, Wy-14,643. Carcinogenesis 18:2029-2033 (1997).
57. Jow L, Mukherjee R. The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPARα and thyroid hormone receptors. J Biol Chem 270:3836-3840 (1995).
58. Varanasi U, Chu RY, Huang Q, Castellon R, Yeldandi AV, Reddy JK. Identification of a peroxisome proliferator responsive element upstream of the human peroxisomal fatty acid acyl coenzyme A oxidase gene. J Biol Chem 271:2147-2155 (1996).
59. Wahli W, Barissant O, Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. J Chem Biol 2:261-266 (1995).
60. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli W, Grimaldi P, Staels B, Yamamoto T, Auwerx J. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 270:19269-19276 (1995).
61. Juge-Aubry CE, Gorla-Bajszczak A, Pernin A, Lemberger T, Wahli W, Burger AG, Meier CA. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for the retinoid X receptor. J Biol Chem 270:18117-18122 (1995).
62. Keller H, Givel F, Perroud M, Wahli W. Signaling cross-talk between peroxisome-proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocrinol 9:794-804 (1995).
63. Larson JL, Templin MV, Wolf DG, Jamison KC, Leininger JR, Mery S, Morgan KT, Wong BA, Conolly RB, Butterworth BE. A 90-day chloroform inhalation study in female and male B6C3F1 mice: implications for risk assessment. Fundam Appl Toxicol 30:118-137 (1996).
64. Pound AW, McGuire LJ. Influence of repeated liver regeneration or hepatic carcinogenesis by diethylnitrosamine in mice. Br J Cancer 37:595-602 (1978).
65. Ledda-Columbano GM, Coni P, Curto M, Giacomini L, Faa G, Sarma DSR, Columbano A. Mitogen-indiced liver hyperplasia does not substitute for compensatory regeneration during promotion of chemical hepatocarcinogenesis. Carcinogenesis 13:379-383 (1992).
66. Buben JA, O'Flaherty EJ. Delineation of the role of metabolism in the hepatoxicity of trichloroethylene and perchloroethylene: a dose-effect study. Toxicol Appl Pharmacol 78:105-122 (1985).
67. Elcombe CR, Rose MS, Pratt IS. Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity. Toxicol Appl Pharmacol 79:365-376 (1985).
68. Dees C, Travis C. The mitogenic potential of trichloroethylene in B6C3F1 mice. Toxicol Lett 69:129-137 (1993).
69. Tucker AN, Sanders VM, Barnes DW, Bradshaw TJ, White K Jr, Sain LE, Borzelleca JF, Munson AE. Toxicology of trichloroethylene in the mouse. Toxicol Appl Pharmacol 62:351-357 (1982).
70. Fisher JW. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites. Environ Health Perspect 108(suppl 2):265-273 (2000).
71. Daniel FB, DeAngelo AB, Stober JA, Olson GR, Page NP. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde and dichloroacetic acid in male B6C3F1 mouse. Fundam Appl Toxicol 19:159-168 (1992).
72. Herren-Freund SL, Pereira MA, Khoury MD, Olson G. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol Appl Pharmacol 90:183-189 (1987).
73. Bull RJ, Sanchez IM, Nelson MA, Larson JL, Lansing AL. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63:341-359 (1990).
74. Pereira MA. Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. Fundam Appl Toxicol 31:192-199 (1996).
75. DeAngelo AB, Daniel FB, Stober JA, Olson GR. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam Appl Toxicol 16:337-347 (1991).
76. DeAngelo AB, George MH, House DE. Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health 58:485-507 (1999).
77. Byington KH, Leibman KC. Metabolism of trichloroethylene in liver microsomes. II: Identification of the reaction product as chloral hydrate. Mol Pharmacol 1:247-254 (1965).
78. Cole WJ, Mitchell RG, Salamonsen RF. Isolation, characterization and quantitation of chloral hydrate as a transient metabolite of trichloroethylene in man using electron capture gas chromatography and mass fragmentography. J Pharm Pharmacol 27:167-171 (1975).
79. Cole WJ, Mitchell RG, Salamonsen RF. Isolation, characterization and quantitation of chloral hydrate as a transient metabolite of trichloroethylene in man using electron capture gas chromatography and mass fragmentography. J Pharm Pharmacol 27:167-171 (1975).
80. Kawamoto T, Hobara T, Kobayashi H, Iwamoto S, Sakai T, Takano T, Miyazaki Y. The metabolic ratio as a function of chloral hydrate dose and intracellular redox as a function of chloral hydrate dose and intracellular redox state in the perfused rat liver. Pharmacol Toxicol 60:325-329 (1987).
81. Templin MV, Parker JC, Bull RJ. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol Appl Pharmacol 123: 1-8 (1993).
82. Templin MV, Stevens DK, Stenner RD, Bonate PL, Tuman D, Bull RJ. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. J Toxicol Environ Health 44:435-447 (1995).
83. Stenner FD, Merdink JL, Templin MV, Stevens DK, Springer DL, Bull RJ. Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid in the metabolism of trichloroethylene. Drug Metab Dispos 25:529-535 (1997).
84. Commandeur JNM, Boogaard PJ, Mulder GJ, Vermeulen NPE. Mutagenicity and cytotoxicity of two regioisomeric mercapturic acids and cysteine conjugates of trichlorothylene. Arch Toxicol 65:373-380 (1991).
85. Dekant W, Metzler M, Henschler D. Identification of S-1,2-dichlorovinyl-N-acetyl-cysteine as a urinary metabolite of trichloroethylene: possible explanation for its nephrocarcinogenicity in male rats. Biochem Pharmacol 35:2455-2458 (1986).
86. Bimer G, Vamvakas S, Dekant W, Henschler D. Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysleine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: implications for the risk of trichloroethene exposure. Environ Health Perspect 99:281-284 (1993).
87. Henschler D, Vamvakas S, Lammert M, DeKant W, Krause B, Thomas B, Ulm K. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethene. Arch Toxicol 69:291-299 (1995).
88. McLaughlin JK, Blot WJ. A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal-cell cancer. Int Arch Occup Environ Health 70:222-231 (1997).
89. Vamvakas S, Bruning T, Thomassen B, Lammert M, Baumiller A, Bolt HM, Dekant W, Henschler D, Ulm K. Renal cell cancer correlated with occupational exposure to trichloroethene. J Cancer Res Clin Oncol 124:374-382 (1998).
90. Richmond RE, Carter JH, Carter HW, Daniel FB, DeAngelo AB. Immunohistochemical analysis of dichloroacetic acid (DCA)-induced hepatocarcinogenesis in male Fischer (F344) rats. Cancer Lett 92:67-76 (1995).
91. DeAngelo AB, Daniel FB, Most BM, Olson GR. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology 114:207-221 (1996).
92. Daniel FB, Meier JR, DeAngelo AB. Advances in research on carcinogenic and genotoxic by-products of chlorine disinfection: chlorinated hydroxyfuranones and chlorinated acetic acids. Ann Ist Super Sanita 29:279-291 (1993).
93. DeAngelo AB, Daniel FB, Most BM, Olson GR. Failure of monochloroacetic acid and trichloroactic acid administered in the drinking water to produce liver cancer in male F344/N rats. J Toxicol Environ Health 52:425-445 (1997).
94. 1 mice by chloral hydrate. Cancer Detect Prev 9:279-288 (1986).
95. Waskell L. A study of the mutagenicity of anesthetics and their metabolites. Mutat Res 57:141-143 (1978).
96. Bignami M, Conti G, Conti L, Crebelli R, Misuraca F, Puglia AM, Randazzo R, Sciandrello G, Carere A. Mutagenicity of halogenated aliphatic hydrocarbons in Salmonella typhimurium, Streptomyces coelicolor and Aspergillis nidulans. Chem-Biol Interact 30:9-23 (1980).
97. Leuschner J, Leuschner F. Evaluation of the mutagenicity of chloral hydrate in vitro and in vivo. Drug Res 41:1101-1103 (1991).
98. Keller DA, Heck HA. Mechanistic studies on chloral toxicity: relationship to trichloroethylene carcinogenesis. Toxicol Lett 42:183-191 (1988).
99. Bronzetti G, Galli A, Corsi C, Cundari E, Del Carratore R, Nieri R, Paolini M. Genetic and biochemical investigation on chloral hydrate in vitro and in vivo. Mutat Res 141:19-22 (1984).
100. Sora S, Carbone MJA. Chloral hydrate, methylmercury hydroxide and ethidium bromide affect chromosomal segregation during meosis of Saccharomyces cerevisiae. Mutat Res 190:13-17 (1987).
101. Furnus CC, Ulrich MA, Terreros MC, Dulout FN. The induction of aneuploidy in cultured Chinese hamster cells by propionaldehyde and chloral hydrate. Mutagenesis 5:323-326 (1990).
102. Vagnarelli P, De Sario A, De Carli L. Aneuploidy induced by chloral hydrate detected in human lymphocytes with Y97 probe. Mutagenesis 5:591-592 (1990).
103. Russo A, Pacchierotti F, Metalli P. Nondisjunction induced in mouse spermatogenesis by chloral hydrate, a metabolite of trichloroethylene. Environ Mutagen 6:695-703 (1984).
104. Daniel FB, Robinson M, Stober JA, Page NP, Olsor GR. Ninety-day toxicity study of chloral hydrate in the Sprague-Dawley rat. Drug Chem Toxicol 15:217-232 (1992).
105. van Heijst ANP, Zimmerman ANE, Pikaar SA. Klinische lessen: Chloralhydraat-net vergeten vergif. Ned T Geneesk 121:1537-1539 (1977).
106. Sanders VM, Kauffmann BM, White KL Jr, Douglas KA, Barnes DW, Sain LE, Bradshaw TJ, Borzelleca JF, Munson AE. Toxicology of chloral hydrate in the mouse. Environ Health Perspect 44:137-146 (1982).
107. Nelson MA, Lansing AJ, Sanchez IM, Bull RJ, Springer DL. Dichloroacetic acid and trichloroacetic acid-induced DNA strand breaks are independent of peroxisome proliferation. Toxicology 58:239-248 (1989).
108. Styles JA, Wyatt I, Coutts C. Trichloroacetic acid: studies on uptake and effects on hepatic DNA and liver growth in mice. Carcinogenesis 12:1715-1719 (1991).
109. Chang LW, Daniel FB, DeAngelo AB. Analysis of DNA strand breaks induced in rodent liver in vivo, hepatocytes in primary culture, and a human cell line by chlorinated acetic acids and chlorinated acetaldehydes. Environ Mol Mutagen 20:277-298 (1992).
110. Austin EW, Parish JM, Kinder D.H, Bull RJ. Lipid peroxidation and formation of 8-hydroxydeoxyguanosine from acute doses of halogenated acetic acids. Fundam Appl Toxicol 31:77-82 (1996).
111. Parrish JM, Austin EW, Stevens DK, Kinder DH, Bull RJ. Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology 110:103-111 (1996).
112. Bessho T, Roy R, Yamamoto K, Nishimura S, Tano K, Mitra, S. Repair of 8-hydroxyguanine in DNA by mammalian N-methylpurine-DNA glycosylase. Proc Natl Acad Sci USA 90:8901-8904 (1993).
113. Pereira MA, Phelps JB. Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett 102:133-141 (1996).
114. Tao L, Li K, Kramer PM, Pereira MA. Loss of heterozygosity on chromosome 6 in dichloroacetic and trichloroacetic acid-induced liver tumors in female B6C3F1 mice. Cancer Lett 108:257-261 (1996).
115. +/- -3.7.LC mouse lymphoma cells. Mutation Res 413:265-276 (1998).
116. DeAngelo AB, Daniel FB, McMillan L, Wernsing P, Savage RE Jr. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol Appl Pharmacol 101:285-298 (1989).
117. Stauber AJ, Bull RJ. Differences in phenotype and cell replicative behavior of hepatic tumors inducted by dichloroacetate (DCA) and trichloroacetate (TCA). Toxicol Appl Pharmacol 144:235-246 (1997).
118. Jirtle RL, Meyer SA. Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β1 expression. Dig Dis Sci 36:659-668 (1991).
119. Stauber AJ, Bull RJ, Thrall BD. Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro. Toxicol Appl Pharmacol 150:287-294 (1998).
120. Sanchez IM, Bull RJ. Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. Toxicology 64:33-46 (1990).
121. Pereira MA. Effect of dichloroacetic acid and trichloroacetic acid upon cell proliferation in B6C3F1 mice. Final Project Report to the AWWA Research Foundation, Denver, CO 1995.
122. Katz R, Tai CN, Deiner RM, McConnel RF, Semonick DE. Dichloroacetate, sodium: 3-month oral toxicity studies in rats and dogs. Toxicol Appl Pharmacol 57:273-287 (1981).
123. Yount EA, Felten SY, O'Connor BL, Peterson RG, Powell RS, Yum MN, Harris RA. Comparison of the metabolic and toxic effects of 2-chloroproprionate and dichloroacetate. J Pharmacol Exp Ther 222:501-508 (1982).
124. 15"). Am J Clin Nutr 33:1179-1182 (1980).
125. DeMarini DM, Perry E, Shelton ML. Dichloroacetic acid and related compounds: induction of prophage in E. coli and mutagenicity and mutation spectra in Salmonella TA100. Mutagenesis 9:429-437 (1994).
126. Woodard G, Lange SW, Nelson KW, Calvery HO. The acute oral toxicity of acetic, chloroacetic, dichloroacetic and trichloroacetic acids. J Ind Hyg Toxicol 23:78-82 (1941).
127. Brusick D. Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ Mutagen 8:879-886 (1986).
128. Giller S, Le Curieux F, Erb F, Marzin D. Comparative genotoxicity of halogenated acetic acids found in drinking water. Mutagenesis 12:321-328 (1997).
129. Fox AW, Yang X, Murli H, Lawlor TE, Cifone MA, Reno FE. Absence of mutagenic effects of sodium dichloroacetate. Fundam Appl Toxicol 32:87-95 (1996).
130. Fuscoe JC, Afshari AJ, George MH, DeAngelo AB, Tice RR, Salman R, Allen JW. In vivo genotoxicity of dichloroacetic acid: Evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay. Environ Mol Mutagen 27:1-9 (1996).
131. Leavitt SA, DeAngelo AB, George MH, Ross JA. Assessment of the mutagenicity of dichloroacetic acid in lacl transgenic B6C3F1 mouse liver. Carcinogenesis 18:2101-2106 (1997).
132. Stacpoole PW, Greene YJ. Dichloroacetate Diabetes Care 15:785-791 (1992).
133. Pratt ML, Roche TE. Mechanism of pyruvate inhibition of kidney pyruvate dehydrogenase kinase and synergistic inhibition by pyruvate and ADP. J Biol Chem 254:7191-7196 (1979).
134. Smith MK, Thrall BD, Bull RJ. Dichloroacetate (DCA) modulates insulin signaling. Toxicologist 36:1133 (1997).
135. Tanaka S, Wands JR. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma prevents transforming growth factor β1-induced apoptosis. Cancer Res 56:3391-3394 (1996).
136. Carter JH, Carter HW, DeAngelo AB. Biochemical, pathologic and morphometric alterations induced in male B6C3F1 mouse liver by short-term exposure to dichloroacetic acid. Toxicol Lett 81:55-71 (1995).
137. Snyder RD, Pullman J, Carter JH, Carter HW, DeAngelo AB. In vivo administration of dichloroacetic acid suppresses spontaneous apoptosis in murine hepatocytes. Cancer Res 55:3702-3705 (1995).
138. Miller JH, Minard KR, Wind RA, Orner GA, Sasser LB, Bull RJ. In vivo MRI measurements of tumor growth induced by dichloroacetate implications for mode of action. Toxicology 145:115-125 (2000).
139. ILSI. An Evaluation of EPA's Proposed Guidelines for Carcinogen Risk Assessment Using Chloroform and Dichloroacetate as Case Studies: Report of an Expert Panel. Washington, DC: International Life Sciences Institute & Health and Environmental Sciences Institute, 1997.
140. Mather GG, Exon JH, Koller LD. Subchronic 90 day toxicity of dichloroacetic and trichloroacetic acid in rats. Toxicology 64:71-80 (1990).
141. Cicmanec JL, Condie LW, Olson GR, Wang S-R. 90-day toxicity study of dichloracetale in dogs. Fundam Appl Toxicol 17:376-389 (1991).
142. Gonzalez-Leon A, Schultz IR, Xu G, Bull RJ. Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water. Toxicol Appl Pharmacol 146:189-195 (1997).
143. Latendressse JR, Pereira MA. Dissimilar characteristics of N-methyl-N-nitrosourea-initiated foci and tumors promoted by dichloroacetic acid or trichloroacetic acid in the liver of female B6C3F1 mice. Toxicol Pathol 25:433-440 (1997).
144. Tao L, Kramer PM, Ge R, Pereira MA. Effect of dichloroacetic acid and trichloroacetic acid on DNA methylation in liver tumors of female B6C3F1 mice. Toxicol Sci 43:139-144 (1998).
145. Greenberg MS, Burton GA, Fisher JW. Physiologically-based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice. Toxicol Appl Pharmacol 154:264-278 (1999).
146. Abbas RR, Seckel CS, Kidney JK, Fisher JW. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab Dispos 24:1340-1346 (1996).
147. Maloney EK, Waxman DJ. trans-Activation of PPARα and PPARγ by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 161:209-218 (1999).
148. Prout MS, Provan WM, Green T. Species differences in response to trichloroethylene. I: Pharmacokinetics in mice and rats. Toxicol Appl Pharmacol 79:389-400 (1985).
149. Hathway DE. Consideration of the evidence for mechanisms of 1,1,2-trichloroethylene metabolism, including new identification of its dichloroacetic acid and trichloroacetic acid metabolites in mice. Cancer Lett 8:263-269 (1980).
150. Bull RJ, Templin M, Larson JL, Stevens DK. The role of dichloroacetate in the hepatocarcinogenicity of trichloroethylene. Toxicol Lett 68:203-211 (1993).
151. Diehl AM, Rai RM. Regulation of signal transduction during liver regeneration. FASEB J 10:216-227 (1996).
152. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 21:1725-1741 (1995).
153. Shalev A, Siegristkaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, Meier CA. The peroxisome-proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137:4499-4502 (1996).
154. Corcoran GB, Fix L, Jones DP, Moslen MT, Nicotera P, Oberhammer FA, Buttyan R. Apoptosis: molecular control point in toxicity. Toxicol Appl Pharmacol 128:169-181 (1994).
155. Preston GA, Lang JE, Maronpot RR, Barrett JC. Regulation of apoptosis by low serum in cells of different stages of neoplastic progression: enhanced susceptibility after loss of senescence gene and decreased susceptibility after loss of a tumor suppressor gene. Cancer Res 52:4214-4223 (1994).
156. Cohen SM, Elwein LB. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 51:6493-6505 (1991).
157. Moolgavkar S, Luebeck G. Multistage carcinogenesis: population-based model for colon cancer. J Natl Cancer Inst 84:610-618 (1992).
158. Stein WD. Analysis of cancer incidence data on the basis of multistage and clonal growth models. Adv Cancer Res 56:161-213 (1991).
159. Burns F, Vanderlaan M, Sivak A, Albert RE. Regression kinetics of mouse skin papillomas. Cancer Res 36:1422-1427 (1976).
160. Grasl-Kraupp B, Ruttkay-Nedecky R, Mullauer L, Taper H, Huber W, Bursch W, Schulte-Hermann R. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor progression. Hepatology 25:906-912 (1997).
161. Anna CH, Maronpot RR, Pereira MA, Foley JF, Malarkey DE, Anderson MW. Ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene-and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis 15(10):2255-2261 (1994).
162. Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101(3):125-156 (1995).
163. Maronpot RR, Devereux TR, Hegi M, Foley JF, Kanno J, Wiseman R, Anderson MW. Hepatic and pulmonary carcinogenicity of methylene chloride in mice: a search for mechanisms. Toxicology 102(1-2):73-81 (1995).
164. Schroeder M, DeAngelo AB, Mass MJ. Dichloroacetic acid reduces Ha-ras codon 61 mutations in liver tumors from female B6C3F1 mice. Carcinogenesis 18(8):1675-1678 (1997).
165. Bruning T, Weirich G, Hornauer MA, Hofler H, Brauch H. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumor suppressor gene. Arch Toxicol 71(5):332-335 (1997).
166. Brauch H, Weirich G, Hornauer MA, Storkel S, Wohl T, Bruning T. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst 91(10):854-861 (1999).
167. DeAngelo AB. Personal communication.